Femtech Insider

🔔 Daré Bioscience, Inc. and the Advanced Research Projects Agency for Health (ARPA-H) will kick off 2025 with a powerful message at Nasdaq MarketSite: “Dare to Invest in Women’s Health.” The organizations will mark the first trading day of the year by ringing the closing bell, bringing attention to the critical need for investment in women’s health innovation. 💰 #femtech #womenshealth #womenshealthinnovation #health #healthcareinnovation #research #science #femhealth #healthcare #ecosystem #nasdaq #policy #funding #investment

🤔 𝗖𝘂𝗿𝗶𝗼𝘂𝘀 𝘄𝗵𝗮𝘁'𝘀 𝗯𝗲𝗲𝗻 𝘂𝗽 𝗶𝗻 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱 𝗼𝗳 𝗳𝗲𝗺𝘁𝗲𝗰𝗵 𝗮𝗻𝗱 𝘄𝗼𝗺𝗲𝗻'𝘀 𝗵𝗲𝗮𝗹𝘁𝗵 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝘁𝗵𝗶𝘀 𝘄𝗲𝗲𝗸? 𝗛𝗲𝗿𝗲'𝘀 𝘁𝗵𝗲 𝗼𝘂𝗿 𝗿𝘂𝗻-𝗱𝗼𝘄𝗻! 👇 💰 French startup Mabel raises €600K to launch psychdelic-based women’s health platform. https://lnkd.in/geN9smRZ 🤖 Women’s Heatlh AI platform Ema - The AI for Women secures additional funding bringing total to $3M. https://lnkd.in/gPw6BNkt 🤝 Wisp teams up with Nourish to enhance GLP-1 weight care services with nutrition support. https://lnkd.in/gtJyfzB4 🏥 Virtual fertility clinic Apricity Fertility to cease operations in January 2025. https://lnkd.in/gm3swGb8 💊 Noom launches Metformin program for weight loss. https://lnkd.in/gtFGPSdR Want updates like this (and more!) in your inbox each week? Follow the link in the comments to subscribe to our industry-leading Femtech Insider newsletter! 📥 #femtech #womenshealthinnovation #research #startup #scaleup #digitalhealth #healthtech #biotech #pharma #venturecapital #vc #partnership #ecosystem #healthequity #genderhealthgap

🤔 𝗖𝘂𝗿𝗶𝗼𝘂𝘀 𝘄𝗵𝗮𝘁'𝘀 𝗯𝗲𝗲𝗻 𝘂𝗽 𝗶𝗻 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱 𝗼𝗳 𝗳𝗲𝗺𝘁𝗲𝗰𝗵 𝗮𝗻𝗱 𝘄𝗼𝗺𝗲𝗻'𝘀 𝗵𝗲𝗮𝗹𝘁𝗵 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝘁𝗵𝗶𝘀 𝘄𝗲𝗲𝗸? 𝗛𝗲𝗿𝗲'𝘀 𝘁𝗵𝗲 𝗼𝘂𝗿 𝗿𝘂𝗻-𝗱𝗼𝘄𝗻! 👇 👶 First baby born using Gameto‘s egg maturation technology that reduces IVF hormone injections. https://lnkd.in/eqm7-dY2 🌱 Lushi launches patient-centric fertility care services with $5M in seed funding. https://lnkd.in/gZT_CSF6 🙏 Mental health platform for Asian Americans Anise Health raises $3M seed round. https://lnkd.in/ecyxUgVD 🩸 #BettiiPod raises £400K to advance its menstrual cup washing solution for public toilets. https://lnkd.in/gmhnQZex 💞 Couples wellness platform #Arya raises $8.5M Series A. https://lnkd.in/g7MdTpnN 🩸 Teen period care brand RedDropCo wins $1M prize from Pharrell Williams’ Black Ambition https://lnkd.in/gTPnJbpC 🚀 WellTheory launches new program targeting link between autoimmune disease and hormonal health. https://lnkd.in/giR2M7Gj ✅ Maven Clinic becomes first women’s health company to receive NCQA health equity accreditation. https://lnkd.in/g24wZCr5 ✅ FemPulse Corporation receives FDA clearance to begin pivotal trial for women’s overactive bladder device. https://lnkd.in/gaDwdP_R 🤝 Ro partners with Eli Lilly and Company to offer direct access to Zepbound weight loss treatment. https://lnkd.in/gPneXAZB 🌱 #Asan launches period tracking app with environmental impact features. https://lnkd.in/g4iPh7EX 🔬 The National Institutes of Health launches DiscoverWHR, a new digital resource to advance women’s health research. https://lnkd.in/gVbcmnF2 💰 Redesign Health secures $175M fund to build healthcare ventures. https://lnkd.in/gBKQEDVW #femtech #womenshealthinnovation #research #startup #scaleup #digitalhealth #healthtech #biotech #pharma #venturecapital #vc #partnership #ecosystem #healthequity #genderhealthgap

✅ Maven Clinic, the world’s largest virtual clinic for women’s and family health, has announced it has received Health Equity Accreditation from the NATIONAL COMMITTEE FOR QUALITY ASSURANCE - NCQA. This makes Maven the first women’s and family health organization to achieve this recognition. 💬 “At Maven, we believe health equity is operational, not only aspirational. This accreditation is a resounding validation of Maven’s ability to deliver equitable outcomes at scale using digital technology.” Neel Shah, Maven Clinic Chief Medical Officer #health #healthcareinnovation #healthequity #healthtech #digitalhealth #certification #femtech #womenshealth #womenshealthinnovation #familyhealth

🩸 The Bettii Pod, a femtech startup developing a menstrual cup/disc washer for public toilets, has secured total funding of £400,000, including £70,000 from Scottish @EDGE and £338,000 from investors Equity Gap and Scottish Enterprise. 💬 "Raising this investment and winning Scottish EDGE funding is a huge step forward for Bettii. This will allow us to continue our work on providing convenient and hygienic solutions for menstruators, all while advancing sustainable practices in FemTech. We’re incredibly grateful for the support of Equity Gap, who have been instrumental in guiding us through this journey. Their expertise and dedication to empowering female-founded businesses have been invaluable." Elaine Galston, CEO of Bettii Ltd. #femtech #womenshealth #womenshealthinnovation #periodcare #publichealth #innovation #healthtech #wash

🚀 The National Institutes of Health (NIH) has announced the launch of #DiscoverWHR, a new research discovery platform developed through a collaboration between the Office of Research on Women’s Health (ORWH) and the National Library of Medicine (NLM). #femtech #womenshealth #womenshealthinnovation #healthcare #womenshealthresearch #health #science #clinicalresearch #hub #ecosystem

🌟 Gameto has announced the world’s first live birth using Fertilo, a new technology that matures eggs outside the body. The birth, which took place at Clinica Santa Isabel in Lima, Peru, represents a significant advancement in fertility treatment by eliminating approximately 80% of hormone injections typically required in conventional IVF. The technology uses engineered ovarian support cells to recreate the natural egg maturation process in a laboratory setting, reducing treatment cycles from the traditional 10-14 days to just three days. 🤱 💬 “We are delighted to celebrate the world’s first live birth conceived using Fertilo. By overcoming the major challenges of conventional IVF, such as long treatment cycles, significant side effects, and the emotional and physical strain, Fertilo provides a potentially faster, safer, and more accessible solution for families. This milestone marks a turning point in reproductive health and highlights the first application of iPSC technology in IVF and the immense potential of our technology.” Dina Radenkovic Turner, CEO & co-founder of Gameto #femtech #womenshealth #womenshealthinnovation #health #healthcare #fertility #reproductivehealth #ivf #milestone #biotech #startup #scaleup #research #clinicalresearch #science

🤝 Healthcare company Ro has announced a collaboration with Eli Lilly and Company to provide patients with streamlined access to Zepbound (tirzepatide) single-dose vials through LillyDirect’s self-pay pharmacy channel. The integration will allow clinically eligible Ro patients to receive the FDA-approved obesity treatment directly through Ro’s platform. Eli Lilly launched LillyDirect earlier this year, marking the first time a major pharmaceutical company has created its own end-to-end digital healthcare platform. 🚀 #health #healthcare #digitalhealth #prescription #healthtech #partnership #pharma

🚀 Lushi, a new startup aimed at transforming the fertility care experience, recently launched with $5 million in funding. The company, founded by former PR executive Jessica Schaefer, introduces its platform with a suite of services designed to make fertility preservation more accessible and less intimidating for women. 💬 "We're the first consumer-first brand in this space focused on solving the real pain points women experience." Jessica Schaefer, Founder & CEO of Lushi #femtech #femhealth #womenshealth #womenshealthinnovation #consumerhealth #reproductivehealth #fertility #eggfreezing #launch

✅ FemPulse Corporation has received FDA Investigational Device Exemption (IDE) approval to begin its EVANESCE II pivotal clinical trial for its wearable bioelectronic device targeting overactive bladder (OAB) in women. The device, called the FemPulse Ring, is designed as a vaginally-inserted, removable treatment option. 💬 "I created the vaginally-inserted and removable FemPulse Ring as an ‘internal wearable’ to provide continuous OAB neuromodulation therapy without requiring surgery. The wearable ring is discreet and patient-managed with a ‘set it and forget it’ approach. Medications can have limited efficacy and intolerable side-effects, so patients discontinue them up to 80% of the time. The trial is randomized against medication to confirm the FemPulse Ring as a first-line alternative to medications." Alexandra Haessler, MD, Fonder & CMO of FemPulse Corporation #femtech #womenshealth #womenshealthinnovation #healthtech #medtech #medicaldevice #pelvichealth #oab #oberactivebladder #incontinence #regulatory #healthtech